The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Rescovitine ID: ALA1087791
PubChem CID: 46881287
Max Phase: Preclinical
Molecular Formula: C19H28N6O
Molecular Weight: 356.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: Rescovitine | Rescovitine|CHEMBL1087791|BDBM50312575
Canonical SMILES: CC[C@H](CO)Nc1nc(NCc2ccccc2)c2c(n1)N(C(C)C)CN2
Standard InChI: InChI=1S/C19H28N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,13,15,21,26H,4,10-12H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1
Standard InChI Key: RMSINZVFNDWCCK-OAHLLOKOSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
0.7539 -4.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0412 -3.5815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0335 -5.2343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7489 -4.8249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6840 -4.8157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6800 -3.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4614 -3.7347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9483 -4.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4678 -5.0662 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7126 -2.9488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1576 -2.3383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5188 -2.7734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0300 -6.0592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7428 -6.4749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7388 -7.2957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0232 -7.7076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0234 -8.5320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7388 -8.9448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4553 -8.5275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4516 -7.7044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4716 -3.5950 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1784 -4.0108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1699 -4.8358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8971 -3.6055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6072 -4.0252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4512 -5.2411 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 13 1 0
5 3 1 0
13 14 1 0
1 2 2 0
14 15 1 0
3 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 1 0
18 19 1 0
9 5 1 0
19 20 2 0
20 15 1 0
4 1 1 0
1 21 1 0
7 10 1 0
21 22 1 0
5 6 2 0
22 23 1 6
10 11 1 0
22 24 1 0
2 6 1 0
24 25 1 0
10 12 1 0
23 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 356.47Molecular Weight (Monoisotopic): 356.2325AlogP: 2.87#Rotatable Bonds: 8Polar Surface Area: 85.34Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.22CX LogP: 3.13CX LogD: 3.10Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.58Np Likeness Score: -0.71
References 1. Ibrahim DA, El-Metwally AM.. (2010) Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors., 45 (3): [PMID:20045222 ] [10.1016/j.ejmech.2009.12.026 ]